Genotype | Male cohort | Female cohort | |||||||
---|---|---|---|---|---|---|---|---|---|
Cases (n = 708) | Control (n = 423) | OR (95 % CI) | P value | Cases (n = 282) | Control (n = 195) | OR (95 % CI) | P value | ||
R219K | RR | 212 | 137 | Ref | Â | 79 | 58 | Ref | |
RK | 337 | 229 | 0.95 (0.72–1.24) | 0.718 | 136 | 88 | 1.13 (0.73–1.74) | 0.566 | |
KK | 159 | 57 | 1.80 (1.24–2.61) | 0.001 | 67 | 49 | 1.0 (0.60–1.65) | 0.987 | |
V825I | VV | 676 | 414 | Ref | Â | 269 | 183 | Ref | |
VI | 32 | 9 | 2.17 (1.02–4.60) | 0.041 | 13 | 12 | 0.73 (0.32–1.65) | 0.458 | |
V422I | VV | 123 | 103 | Ref | Â | 55 | 44 | Ref | |
VI | 376 | 232 | 1.35 (0.99–1.84) | 0.052 | 147 | 65 | 1.80 (1.10–2.96) | 0.018 | |
II | 209 | 88 | 1.98 (1.38–2.85) | 0.0002 | 80 | 86 | 0.74 (0.45–1.22) | 0.246 | |
TaqIB | B1B1 | 261 | 124 | Ref | Â | 115 | 59 | Ref | |
B1B2 | 340 | 247 | 0.65 (0.49–0.85) | 0.002 | 114 | 74 | 0.79 (0.51–1.21) | 0.282 | |
B2B2 | 107 | 52 | 0.97 (0.65–1.45) | 0.91 | 53 | 62 | 0.43 (0.27–0.71) | 0.0008 |